These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function. Gatenby P; Basten A; Adams E J Clin Lab Immunol; 1980 May; 3(3):209-16. PubMed ID: 7420408 [TBL] [Abstract][Full Text] [Related]
10. Esophageal cancer associated with chronic mucocutaneous candidiasis. Could chronic candidiasis lead to esophageal cancer? Domingues-Ferreira M; Grumach AS; Duarte AJ; De Moraes-Vasconcelos D Med Mycol; 2009 Mar; 47(2):201-5. PubMed ID: 18798115 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic criteria and current therapeutic directions in Candida infection with special reference to the oral region]. Fustini F; Montanari G Minerva Stomatol; 1981; 30(5):403-8. PubMed ID: 7033763 [No Abstract] [Full Text] [Related]
14. Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis. Leigh JE; Barousse M; Swoboda RK; Myers T; Hager S; Wolf NA; Cutright JL; Thompson J; Sobel JD; Fidel PL J Infect Dis; 2001 Jan; 183(2):277-285. PubMed ID: 11120933 [TBL] [Abstract][Full Text] [Related]
15. A girl with eczematous lesions, multiple recurrent skin abscesses and mucocutaneous candidiasis. Petiti Martin GH; Buil MV; Calderón MB; Allende LM; Frutos JO Pediatr Dermatol; 2013; 30(5):621-2. PubMed ID: 24016286 [No Abstract] [Full Text] [Related]
16. Immunotherapy in cancer treatment. A comparative study with chronic muco-cutaneous candidiasis. Higgs JM Clin Oncol; 1980 Jun; 6(2):95-112. PubMed ID: 6967793 [No Abstract] [Full Text] [Related]
17. Protective and pathologic immune responses against Candida albicans infection. Ashman RB Front Biosci; 2008 May; 13():3334-51. PubMed ID: 18508436 [TBL] [Abstract][Full Text] [Related]